Davadost Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 7.56 M
as on 07-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.35 M
as on 07-07-2024
- Satisfied Charges ₹ 5.00 M
as on 07-07-2024
- Revenue %
(FY 2020)
- Net Worth 4345.18%
(FY 2020)
- Total Assets 531.57%
(FY 2020)
About Davadost Pharma
The Corporate was formerly known as Oakwood Consulting Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 7.56 M.
The company currently has active open charges totaling ₹2.35 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Davadost Pharma Private Limited India is Amit Choudhary as CEO. Amit Choudhary, Yash Harlalka, Nikita Choudhary, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51100WB2014PTC203164
- Company No.
203164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Davadost Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Choudhary | CEO | 28-Oct-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Chandiramani  | Director | 07-Apr-2020 | Current |
| Nikita Choudhary | Director | 19-Aug-2014 | Current |
| Yash Harlalka | Director | 04-Oct-2021 | Current |
| Punit Poddar | Director | 28-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Davadost Pharma.
Davadost Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 4345.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Davadost Pharma?
In 2020, Davadost Pharma had a promoter holding of 72.65% and a public holding of 27.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Updater Services LimitedActive 21 years 1 monthAmit Choudhary and Sunil Chandiramani are mutual person
Dawaa Dost Retail Private LimitedActive 3 years 1 monthAmit Choudhary and Yash Harlalka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Oct 2022 | ₹2.35 M | Open |
Others Creation Date: 24 Mar 2022 | ₹5.00 M | Satisfied |
How Many Employees Work at Davadost Pharma?
Davadost Pharma has a workforce of 159 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Davadost Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Davadost Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
